| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 05/17/2006 | EP1656949A1 Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1265616B1 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | EP0894136B1 Method of treating muscular disorders |
| 05/17/2006 | CN1774635A Anti-epileptogenic agents |
| 05/17/2006 | CN1774429A Medicinal composition |
| 05/17/2006 | CN1256086C Use of 5-hydroxymethyl furfural in preparation of drug for nerve system |
| 05/16/2006 | US7045529 Imidazopyrimidinyl and imidazopyri dinyl derivatives |
| 05/16/2006 | US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field |
| 05/16/2006 | US7045520 Opioid receptor active compounds |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045152 Pulmonary disorders in which the S-nitrosoglutathione(GSNO) pool or glutathione pool in the lung is depleted and where reactive oxygen species in lung are increased, are treated by delivering into the lung an agent causing repletion of GSNO |
| 05/16/2006 | US7045148 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 05/16/2006 | US7045118 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/11/2006 | WO2006049258A1 Polymeric polyphenol extracted from fermented tea, therapeutic agent for mitochondrial disease, preventive/therapeutic agent for diabetes mellitus, and food or beverage |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100184 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 05/11/2006 | US20060100159 Preventing desensitization of receptors |
| 05/11/2006 | US20060099672 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types for example |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/10/2006 | EP1655023A1 Botulinum toxin implat |
| 05/10/2006 | EP1379694B1 Methods and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 05/10/2006 | EP1224205B1 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 05/10/2006 | CN1771044A Composition for administration of iron for the treatmrnt of restless legs syndrome |
| 05/10/2006 | CN1768746A Novel medical use of matrine alkaloid |
| 05/10/2006 | CN1255049C Functional agent for decomposing nicotine and method of preparing the same |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | CA2322501C Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/04/2006 | WO2006046557A1 Abnormal protein removing composition |
| 05/04/2006 | US20060094746 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-hydroxythieno[2,3-c]isoquin-5(4H)-one, used for treating tumor diseases, leukaemia, sarcoma, tissue damage due to ischemia and reperfusion, inflammatory disease, retinal ischemia or brain trauma |
| 05/04/2006 | US20060093690 Novel therapeutic use of polypodium extracts |
| 05/04/2006 | US20060093612 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 05/04/2006 | US20060093603 ErbB4 antagonists |
| 05/04/2006 | US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/03/2006 | EP1232748B1 Use of substituted nitrobenzene derivatives for the treatment of diseases caused by bacteria, fungi and viruses |
| 05/03/2006 | EP1227805B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/03/2006 | EP1104309B1 Co-lyophilized complex comprising a nucleic acid vector and a formulating agent |
| 05/03/2006 | CN1254469C Arylsulfonyl derivatives with 5-HT6 receptor affinity |
| 05/02/2006 | US7037719 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 05/02/2006 | US7037702 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents |
| 05/02/2006 | US7037533 Functional agent for decomposing nicotine and method of preparing the same |
| 04/27/2006 | WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 04/27/2006 | WO2003040333A3 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/27/2006 | US20060089356 Substituted imidazoles as cannabinoid receptor modulators |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | US20060088508 Method for obtaining characterized muscle-derived cell populations and uses |
| 04/26/2006 | EP1650201A1 Benzoxazepine compound |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/25/2006 | US7034044 NMDA (N-methyl-D- aspartate)-receptor subtype blockers and are used in the treatment or prevention of CNS disorders i.e. Alzheimer's, Parkinson's, etc. |
| 04/25/2006 | US7034042 Corticotropin releasing factor receptor antagonist |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7033770 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 04/25/2006 | US7033575 Delivery of physiologically active compounds through an inhalation route |
| 04/20/2006 | US20060084677 2-sulfo, sulfanyl, sulfinyl, sulfonyl, or sulfamyl-5-substituted-6-sulfonyl quinolines; sulfiding, oxidation, dehalogenation or aralkylation of the 6-sulfonylquinoline; selective cyclooxygenase-2 inhibitors, analgesics; side effect reduction |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084661 IL-8 receptor antagonists |
| 04/20/2006 | US20060084598 Administering to the patient about 15 to about 360 mg of alpha-1-antitrypsin per kg patient body mass, and repeating the administration at least once with a periodicity of between 3 and 31 days |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | EP1370559B1 Triazolopyridines as anti-inflammatory agents |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1237886B1 Meglumine salt of a specific quinolinecarboxylic acid compound active on nmda receptors |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | CN1761452A Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 04/19/2006 | CN1252239C Wine of twin ginseng and preparation method |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030128 Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 04/18/2006 | US7030126 Use of polyamine analogs for amyotrophic lateral sclerosis |
| 04/18/2006 | US7029898 Comprises chimeric polypeptide with hydrolase and mitogen activated protein kinase activity for diagnosis and treatment of cell proliferation and differentiation disorders |
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/18/2006 | US7029658 Delivery of antidepressants through an inhalation route |
| 04/18/2006 | CA2431683C Migraine headache eye-rinse remedy solution |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079551 Treatment of neurodegenerative diseases and cancer of the brain using histone deacetylase inhibitors |
| 04/13/2006 | US20060079503 Thiazolidinones and the use therof as polo-like kinase inhibitors |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078596 Treatment of muscle fatigue |
| 04/12/2006 | EP1423436B1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/11/2006 | US7026516 Compounds with high monoamine transporter affinity |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026361 Dispersion stability; forming protective colloid; bioavailability; hypotensive agents, oral diseases |
| 04/11/2006 | US7026349 Sulfonamides |